Literature DB >> 27885891

Wiskott-Aldrich syndrome in a child presenting with macrothrombocytopenia.

Jose Maria Bastida1, Monica Del Rey2, Nuria Revilla3, Rocio Benito2, Martin Perez-Andrés4, Berta González5, Susana Riesco6, Kamila Janusz2, Jose Padilla3, Ana Hortal Benito-Sendin6, David Bueno5, Elena Blanco3, Maria Hernández-Rivas1,2, Vicente Vicente3,7, Jose Rivera3,7, Ramon González-Porras1, Maria Luisa Lozano3,7.   

Abstract

Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive disease resulting from variants in the WAS gene, characterized by a triad of immunodeficiency, eczema, and thrombocytopenia. Despite the fact that WAS is traditionally differentiated from immune thrombocytopenia (ITP) by small size of WAS platelets, in practice, microthrombocytopenia may occasionally not be present, and in certain cases, WAS patients exhibit some parallelism to ITP patients. We characterized one patient presenting with the classic form of the disease but increased mean platelet volume. Molecular studies revealed a novel hemizygous 1-bp deletion in WAS gene, c.802delC, leading to a frameshift and stop codon at amino acid 308 (p.Arg268Glyfs*40). Next-generation sequencing of a total of 70 additional genes known to harbor variants implicated in inherited platelet disorders did not identify additional defects. The pathogenesis of macrothrombocytopenia in this case is not known, but probably the coexistence of a still unidentified additional genetic variant might be involved.

Entities:  

Keywords:  Genetic diagnosis; Wiskott–Aldrich syndrome; immune thrombocytopenia; inherited thrombocytopenia; next-generation sequencing

Mesh:

Year:  2016        PMID: 27885891     DOI: 10.1080/09537104.2016.1246715

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  6 in total

1.  Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing.

Authors:  Jose María Bastida; Sara Morais; Veronica Palma-Barqueros; Rocio Benito; Nuria Bermejo; Mutlu Karkucak; Maria Trapero-Marugan; Natalia Bohdan; Mónica Pereira; Ana Marin-Quilez; Jorge Oliveira; Yusuf Yucel; Rosario Santos; Jose Padilla; Kamila Janusz; Catarina Lau; Marta Martin-Izquierdo; Eduarda Couto; Juan Francisco Ruiz-Pividal; Vicente Vicente; Jesus Maria Hernández-Rivas; Jose Ramon González-Porras; Maria Luisa Lozano; Margarida Lima; Jose Rivera
Journal:  Ann Med       Date:  2019-04-16       Impact factor: 4.709

Review 2.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

3.  When WAS Gene Diagnosis Is Needed: Seeking Clues Through Comparison Between Patients With Wiskott-Aldrich Syndrome and Idiopathic Thrombocytopenic Purpura.

Authors:  Ying-Ying Jin; Jing Wu; Tong-Xin Chen; Ji Chen
Journal:  Front Immunol       Date:  2019-07-09       Impact factor: 7.561

Review 4.  Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia.

Authors:  José María Bastida; José Ramón Gonzalez-Porras; José Rivera; María Luisa Lozano
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

5.  Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.

Authors:  José M Bastida; María L Lozano; Rocío Benito; Kamila Janusz; Verónica Palma-Barqueros; Mónica Del Rey; Jesús M Hernández-Sánchez; Susana Riesco; Nuria Bermejo; Hermenegildo González-García; Agustín Rodriguez-Alén; Carlos Aguilar; Teresa Sevivas; María F López-Fernández; Anna E Marneth; Bert A van der Reijden; Neil V Morgan; Steve P Watson; Vicente Vicente; Jesús M Hernández-Rivas; José Rivera; José R González-Porras
Journal:  Haematologica       Date:  2017-10-05       Impact factor: 9.941

6.  A Homozygous Mutation in 5' Untranslated Region of TNFRSF11A Leading to Molecular Diagnosis of Osteopetrosis Coinheritance With Wiskott-Aldrich Syndrome.

Authors:  Tianping Chen; Jun Sun; Guanghui Liu; Chuangao Yin; Haipeng Liu; Lijun Qu; Shijin Fang; Ash Shifra; Gil Gilad
Journal:  J Pediatr Hematol Oncol       Date:  2021-03-01       Impact factor: 1.170

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.